{"transactions":[{"id":811400,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":53072,"kind":"person","name":"Prince Joshua S.","position":1,"cik":"0001998663","reported_name":"Prince Joshua S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-04-10T00:40:22.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":56248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the \"Grant Date\"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date."}],"balance_after":56248,"derivative":{"exercise_price":0.5358,"expiration_date":"2036-04-07","underlying":"Common Stock","underlying_shares":56248},"source":{"system":"sec-edgar","filing":"0001998663-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000199866326000006/edgardoc.xml","form_type":"4"}},{"id":811399,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":53072,"kind":"person","name":"Prince Joshua S.","position":1,"cik":"0001998663","reported_name":"Prince Joshua S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-04-10T00:40:22.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":18752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the \"Grant Date\"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date."}],"balance_after":18752,"derivative":{"exercise_price":0.5358,"expiration_date":"2036-04-07","underlying":"Common Stock","underlying_shares":18752},"source":{"system":"sec-edgar","filing":"0001998663-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000199866326000006/edgardoc.xml","form_type":"4"}},{"id":950878,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":53072,"kind":"person","name":"Prince Joshua S.","position":1,"cik":"0001998663","reported_name":"Prince Joshua S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-06T01:51:53.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":4386,"price":0.5626,"value":2467.5636,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."}],"balance_after":15249,"source":{"system":"sec-edgar","filing":"0001998663-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000199866326000002/edgardoc.xml","form_type":"4"}},{"id":1097738,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":53072,"kind":"person","name":"Prince Joshua S.","position":1,"cik":"0001998663","reported_name":"Prince Joshua S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-07-01T21:51:38.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":4882,"price":1.7,"value":8299.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."}],"balance_after":10863,"source":{"system":"sec-edgar","filing":"0001415889-25-018759","document":"form4-07012025_090735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588925018759/form4-07012025_090735.xml","form_type":"4"}},{"id":1101626,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":53072,"kind":"person","name":"Prince Joshua S.","position":1,"cik":"0001998663","reported_name":"Prince Joshua S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:15:09.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the \"Grant Date\"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date."}],"balance_after":100000,"derivative":{"exercise_price":1.96,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-018202","document":"form4-06252025_050605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588925018202/form4-06252025_050605.xml","form_type":"4"}},{"id":1304244,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":53072,"kind":"person","name":"Prince Joshua S.","position":1,"cik":"0001998663","reported_name":"Prince Joshua S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-01-13T22:40:58.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":3310,"price":2.5075,"value":8299.825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019  Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."}],"balance_after":5981,"source":{"system":"sec-edgar","filing":"0001415889-25-001402","document":"form4-01132025_100154.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588925001402/form4-01132025_100154.xml","form_type":"4"}},{"id":1462617,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":53072,"kind":"person","name":"Prince Joshua S.","position":1,"cik":"0001998663","reported_name":"Prince Joshua S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-07-02T22:10:04.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":2671,"price":2.958,"value":7900.818,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended."}],"balance_after":2671,"source":{"system":"sec-edgar","filing":"0001415889-24-019028","document":"form4-07022024_100701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588924019028/form4-07022024_100701.xml","form_type":"4"}},{"id":1468672,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":53072,"kind":"person","name":"Prince Joshua S.","position":1,"cik":"0001998663","reported_name":"Prince Joshua S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T01:29:04.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the \"Vesting Start Date\"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date."}],"balance_after":150000,"derivative":{"exercise_price":3.23,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-24-018276","document":"form4-06272024_010600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588924018276/form4-06272024_010600.xml","form_type":"4"}}]}